A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer

Published:2004-05 Issue:2 Volume:85 Page:143-150
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Lyman Gary H.,Green Stephanie J.,Ravdin Peter M.,Geyer Charles E.,Russell Christy A.,Balcerzak Stanley P.,Thomas Budd G.,Martino Silvana

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.springerlink.com/index/pdf/10.1023/B:BREA.0000025405.63953.f9

Reference22 articles.

1. Hortobagyi GN: Treatment of breast cancer. New England J Med 339: 974–984, 1998

2. Gianni L: Paclitaxel plus doxorubicin in metastatic breast cancer: the Milan expierence. Oncology 12(1 Suppl 1): 13–15, 1998

3. Gianni L, Munzone E, Capri G, Fulfaro F, Tarenzi E, Villani F, Spearfish C, Laffranchi A, Caraceni A, Martini C et al.: Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol 13: 2688–2699, 1995

4. Gehl J, Boesgaard M, Paaske T, Vittrup Jensen B, Dombernowsky P: Combined doxorubicin and paclitaxel in advanced breast cancer: effective and cardiotoxic. Ann Oncol 7: 687–693, 1996

5. Green S, Weiss G: Southwest Oncology Group standard response criteria endpoint definitions and toxicity criteria. Invest New Drugs 10: 239–253, 1992

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactive oxygen species produced by photodynamic therapy enhance docosahexaenoic acid lipid peroxidation and induce the death of breast cancer cells;Colloids and Surfaces B: Biointerfaces;2024-09

2. Synchronized Codelivery of Combination Chemotherapies Intratumorally Using a Lipidic Lyotropic Liquid Crystal System;ACS Applied Materials & Interfaces;2024-05-23

3. Co-delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers;Molecular Pharmaceutics;2015-09-30

4. Taxane-containing regimens for metastatic breast cancer;Cochrane Database of Systematic Reviews;2015-06-10

5. Role of Taxane and Anthracycline Combination Regimens in the Management of Advanced Breast Cancer;Medicine;2015-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3